InvestorsHub Logo
Followers 237
Posts 10817
Boards Moderated 0
Alias Born 07/17/2006

Re: Atom0aks post# 229842

Sunday, 11/24/2019 7:56:15 PM

Sunday, November 24, 2019 7:56:15 PM

Post# of 425892
AtomO..

Whether or not the primary cohort showed significance is only part of the story...The R-I trial was not powered to detect significance in the primary cohort...The reality is that the primary cohort although being a smaller group than the secondary showed the same RRRs as the secondary...Its just there were fewer of them...And that is the reason the primary cohort should be included (and probably will be ) on the label..

The point was Vascepa was not less effective than the secondary group..the RRRs were basically the same...

":>) JL
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News